Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Fusion Bioline Vascular Graft

K-Number: K252445 · 2026-04-27

Decision Date2026-04-27
Product CodeDSY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Fusion Bioline Vascular Graft is a medical device manufactured by Maquet Cardiovascular, LLC. It received FDA 510(k) clearance on 2026-04-27 under approval number K252445. The device is classified under product code DSY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Fusion Bioline Vascular Graft?

Fusion Bioline Vascular Graft is a medical device that received FDA 510(k) clearance on 2026-04-27. It is manufactured by Maquet Cardiovascular, LLC. The 510(k) number is K252445.

When was Fusion Bioline Vascular Graft approved by the FDA?

Fusion Bioline Vascular Graft received FDA 510(k) clearance on 2026-04-27, under approval number K252445.

What company makes Fusion Bioline Vascular Graft?

Fusion Bioline Vascular Graft is manufactured by Maquet Cardiovascular, LLC.

What is the FDA product code for Fusion Bioline Vascular Graft?

The FDA product code for Fusion Bioline Vascular Graft is DSY.

Related Clinical Trials

Other Devices by Maquet Cardiovascular, LLC

View all 8 devices →

Related Devices (Code: DSY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.